Correlation Between China SXT and Canopy Growth

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China SXT and Canopy Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China SXT and Canopy Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China SXT Pharmaceuticals and Canopy Growth Corp, you can compare the effects of market volatilities on China SXT and Canopy Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China SXT with a short position of Canopy Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of China SXT and Canopy Growth.

Diversification Opportunities for China SXT and Canopy Growth

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between China and Canopy is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding China SXT Pharmaceuticals and Canopy Growth Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canopy Growth Corp and China SXT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China SXT Pharmaceuticals are associated (or correlated) with Canopy Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canopy Growth Corp has no effect on the direction of China SXT i.e., China SXT and Canopy Growth go up and down completely randomly.

Pair Corralation between China SXT and Canopy Growth

Given the investment horizon of 90 days China SXT Pharmaceuticals is expected to generate 2.89 times more return on investment than Canopy Growth. However, China SXT is 2.89 times more volatile than Canopy Growth Corp. It trades about 0.08 of its potential returns per unit of risk. Canopy Growth Corp is currently generating about -0.48 per unit of risk. If you would invest  39.00  in China SXT Pharmaceuticals on October 1, 2024 and sell it today you would earn a total of  2.80  from holding China SXT Pharmaceuticals or generate 7.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

China SXT Pharmaceuticals  vs.  Canopy Growth Corp

 Performance 
       Timeline  
China SXT Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China SXT Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Canopy Growth Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Canopy Growth Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

China SXT and Canopy Growth Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China SXT and Canopy Growth

The main advantage of trading using opposite China SXT and Canopy Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China SXT position performs unexpectedly, Canopy Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canopy Growth will offset losses from the drop in Canopy Growth's long position.
The idea behind China SXT Pharmaceuticals and Canopy Growth Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Fundamental Analysis
View fundamental data based on most recent published financial statements
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities